OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abnormal Brain Bioenergetics in First-Episode Psychosis
Çağrı Yüksel, Xi Chen, Virginie‐Anne Chouinard, et al.
Schizophrenia Bulletin Open (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Magnetic Resonance Spectroscopy Studies of Brain Energy Metabolism in Schizophrenia: Progression from Prodrome to Chronic Psychosis
Abigail Stein, Chenyanwen Zhu, Fei Du, et al.
Current Psychiatry Reports (2023) Vol. 25, Iss. 11, pp. 659-669
Closed Access | Times Cited: 11

Poor self-reported sleep is associated with prolonged white matter T2 relaxation in psychotic disorders
Ümit Haluk Yeşilkaya, Xi Chen, Lauren Watford, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access

Creatine – Creatine Phosphate System in Healthy Persons and in Patients with Mental Disorders
Burbaeva GSh, И. С. Бокша, О. К. Савушкина, et al.
Psikhiatriya (2025) Vol. 22, Iss. 5, pp. 94-106
Closed Access

Microglial-Neuronal Interactions in the Caudate Nucleus in Schizophrenia with Different Courses
Olga V. Vikhreva, В. И. Рахманова, Uranova Na
Neuroscience and Behavioral Physiology (2025)
Closed Access

Creatine metabolism in psychosis and catatonia: A case report and review of the literature
Sophie Scharner, Terrance M. Dolan, Eric P. Hazen
Psychiatry Research Case Reports (2025), pp. 100260-100260
Open Access

Schizophrenia, a disease of impaired dynamic metabolic flexibility: A new mechanistic framework
Zoltán Sarnyai, Dorit Ben‐Shachar
Psychiatry Research (2024) Vol. 342, pp. 116220-116220
Open Access | Times Cited: 3

The role of mitochondria in the pathophysiology of schizophrenia: A critical review of the evidence focusing on mitochondrial complex one
Thomas Whitehurst, Oliver Howes
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 449-464
Closed Access | Times Cited: 23

Ketogenic Diet and Inflammation: Implications for Mood and Anxiety Disorders
Roy El Karkafi, Tammy Gebara, Michael Salem, et al.
Advances in experimental medicine and biology (2023), pp. 537-554
Closed Access | Times Cited: 5

Fast in vivo assay of creatine kinase activity in the human brain by 31P magnetic resonance fingerprinting
Mark Widmaier, Song‐I Lim, Daniel Wenz, et al.
NMR in Biomedicine (2023) Vol. 36, Iss. 11
Open Access | Times Cited: 4

From periphery immunity to central domain through clinical interview as a new insight on schizophrenia
Wirginia Krzyściak, Marta Szwajca, Natalia Śmierciak, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Impact of lifetime stressor exposure on neuroenergetics in schizophrenia spectrum disorders
Joshua Chiappelli, Anya Savransky, Yizhou Ma, et al.
Schizophrenia Research (2024) Vol. 269, pp. 58-63
Closed Access | Times Cited: 1

Microglia-neuron interactions in the caudate nucleus in different course of schizophrenia
Olga V. Vikhreva, В. И. Рахманова, Uranova Na
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 7, pp. 154-154
Closed Access | Times Cited: 1

Fast 3D31P B1+ mapping with a weighted stack of spiral trajectory at 7 T
Mark Widmaier, Antonia Kaiser, Salomé Baup, et al.
Magnetic Resonance in Medicine (2024)
Open Access | Times Cited: 1

Intranasal insulin increases brain glutathione (GSH) and enhances antioxidant capacity in healthy participants, but not in those with early psychotic disorders.
Virginie‐Anne Chouinard, Wirya Feizi, Xi Chen, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024)
Closed Access | Times Cited: 1

Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetically Targeted Therapeutic Approaches
И. С. Бокша, T. A. Prokhorova, О. К. Савушкина, et al.
Neurochemical Journal (2023) Vol. 17, Iss. 4, pp. 676-690
Closed Access | Times Cited: 3

Disrupted leptin-fatty acid biosynthesis is an early manifestation of metabolic abnormalities in schizophrenia
Mohammad M. Khan
World Journal of Psychiatry (2022) Vol. 12, Iss. 6, pp. 827-842
Open Access | Times Cited: 3

Differentially Altered Metabolic Pathways in the Amygdala of Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder
Xiaolu Zhang, Jake Valeri, Mahmoud Ali Eladawi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Expression level of myocardial enzymes in patients with schizophrenia: Predictive value in the occurrence of violence
Wei‐Min He, Xinyuan Zhang, Wei-Gen Xie, et al.
World Journal of Psychiatry (2024) Vol. 14, Iss. 9, pp. 1346-1353
Open Access

Fast in vivo assay of creatine kinase activity in the human brain by 31P magnetic resonance fingerprinting
Mark Widmaier, Song‐I Lim, Daniel Wenz, et al.
Research Square (Research Square) (2023)
Open Access

Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetic-Targeted Therapeutic Approaches
И. С. Бокша, T. A. Prokhorova, О. К. Савушкина, et al.
Нейрохимия (2023) Vol. 40, Iss. 4, pp. 406-422
Closed Access

Fast in vivo assay of creatine kinase in human brain by 31P magnetic resonance fingerprinting
Mark Widmaier, Song‐I Lim, Daniel Wenz, et al.
Research Square (Research Square) (2022)
Open Access

Page 1 - Next Page

Scroll to top